glp 1 china More Chinese biotechs challenge GLP-1 dominance in diabetes China's New Twice-Monthly GLP-1 Shot

Beyond this narrow indication, methylene blue is widely employed off-label for intraoperative sentinel lymph node mapping, ifosfamide-induced neurotoxicity, and refractory vasoplegic (distributive) shock, with additional investigational uses in neuroprotection (Alzheimer disease, stroke, traumatic brain injury), psychiatric disorders (as a monoamine oxidase inhibitor), and even historical antimalarial therapy

Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up

Clinical evaluation of a growth hormone-releasing peptide (Ipamorelin)

Younger adults (35-45 years) with recent growth hormone decline often respond well to 200-300mcg daily, achieving robust 60-100 ng/mL IGF-1 increases